Informace o publikaci
Increasing the infliximab dose in rheumatoid arthritis patients: a randomized, double blind study failed to confirm its efficacy.
| Autoři | |
|---|---|
| Rok publikování | 2009 |
| Druh | Článek v odborném periodiku |
| Časopis / Zdroj | Annals of the Rheumatic Diseases |
| Fakulta / Pracoviště MU | |
| Citace | |
| Obor | Ostatní lékařské obory |
| Klíčová slova | rheumatoid arthritis; therapy; infliximab; dose escalation |
| Popis | In this study, increasing the infliximab dose from 3 to 5 mg/kg in RA patients with residual disease activity did not improve efficacy but moderately increased toxicity. These data indicate that a switch to another biological treatment would be a more appropriate strategy in incomplete responders. |